HomeALZCUR • STO
add
AlzeCure Pharma AB
Previous close
kr 2.33
Day range
kr 2.24 - kr 2.46
Year range
kr 0.81 - kr 3.86
Market cap
203.96M SEK
Avg Volume
147.57K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.71M | -4.66% |
Net income | -9.33M | 4.37% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.66M | 4.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.50M | 8.24% |
Total assets | 34.44M | 7.61% |
Total liabilities | 8.25M | 0.28% |
Total equity | 26.18M | — |
Shares outstanding | 88.30M | — |
Price to book | 7.77 | — |
Return on assets | -63.03% | — |
Return on capital | -78.65% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.33M | 4.37% |
Cash from operations | -7.56M | 9.52% |
Cash from investing | -124.00K | — |
Cash from financing | 0.00 | — |
Net change in cash | -7.69M | 8.04% |
Free cash flow | -4.43M | 10.92% |
About
Founded
2012
Website
Employees
11
